Somatostatin, cholecystokinin and neuropeptide Y mRNAs in normal and weaver mouse brain

Journal of Neural Transmission

Volumn 109, Issue 11, 2002, Pages 1337-1351

  Zavitsanou, K ^a   Triarhou, L C ^b   Kouvelas, E D ^a   Mitsacos, A ^a   Palacios, J M ^c,d   Mengod, G ^c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF MACEDONIA   (Greece)

^c INST D INVESTIGACIONS B   (Spain)

^d Almirall Prodesfarma S A   (Spain)

Author keywords

Dopamine; mRNA expression; Neuropeptides

Indexed keywords

CHOLECYSTOKININ; DOPAMINE; MESSENGER RNA; NEUROPEPTIDE Y; SOMATOSTATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; GENE EXPRESSION; HIPPOCAMPUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULAR FORMATION; THALAMUS NUCLEUS; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MOUSE MUTANT; UPREGULATION;

ANIMALS; BRAIN; CHOLECYSTOKININ; DISEASE MODELS, ANIMAL; DOPAMINE; IN SITU HYBRIDIZATION; MICE; MICE, NEUROLOGIC MUTANTS; NEUROPEPTIDE Y; RNA, MESSENGER; SOMATOSTATIN; UP-REGULATION;

EID: 0036832534     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0759-7     Document Type: Article

References (55)

1. Beal MF, Martin JB (1983) Effects on somatostatin-like immunoreactivity in the rat striatum. Brain Res 266:67-73
2. Bendotti C, Hohmann C, Forloni G, Reevers R, Coyle JT, Oster-Granite ML (1990) Developmental expression of somatostatin in mouse brain. II. In situ hybridization. Dev Brain Res 53(1): 26-39
3. Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol 2. Elsevier, Amsterdam, pp 55-122
4. Boyson SJ, McGonigle P, Molinoff PB (1986) Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6: 3177-3188
5. Caberlotto L, Fuxe K, Hurd YL (2000) Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala and striatum. J Chem Neuroanat 20: 327-337
6. Campbell K, Wictorin K, Björklund A (1992) Differential regulation of neuropeptide mRNA expression in intrastriatal transplants by host dopaminergic afferents. Proc Natl Acad Sci USA 89:10489-10493
7. Cenci MA, Campbell K, Björklund A (1993) Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 57:275-296
8. Cornwall J, Cooper JD, Phillipson OT (1990) Projections to the rostral reticular thalamic nucleus in the rat. Exp Brain Res 80: 151-171
9. Czyzak A, Chocyk A, Mackowiak M, Fijal K, Wedzong K (2000) Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. Mol Brain Res 85:209-217
10. Deschenes RJ, Lorentz LJ, Haun RS, Roos BA, Collier KJ, Dixon JE (1984) Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci USA 81:726-730
11. Delfs JM, Ciaramitaro VM, Soghomonian J-J, Chesselet MF (1996) Unilateral nigrostriatal lesions induce a bilateral increase in glutamate decarboxylase messenger RNA in the reticular thalamic nucleus. Neuroscience 71: 383-395
12. Ding XZ, Mocchetti I (1992) Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Mol Brain Res 12:77-83
13. Fitzpatrick-McElligott S, Card JP, Lewis ME, Baldino F Jr (1998) Neuronal localization of presomatostatin mRNA in the rat brain with in situ hybridization histochemistry. J Comp Neurol 273: 558-572
14. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, London
15. Gandia JA, De Las Heras S, Garcia M, Gimenez-Amaya JM (1993) Afferent projections to the reticular thalamic nucleus from the globus pallidus and substantia nigra in the rat. Brain Res Bull 32: 351-358
16. Gerfen CR, McGindy JF, Young WS (1991) Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11: 1016-1031
17. Giardino L, Zanni M, Pozza M, Betteli C, Covelli V (1999) Dopamine receptors in the striatum of rats exposed to repeated restraint stress and alprazolam treatment. Eur J Pharmacol 344: 143-147
18. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC (1995) Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci 18: 527-535
19. Kerkerian L, Bosler O, Pelletier G, Nieoullon A (1986) Striatal neuropeptide Y neurons are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence. Neurosci Lett 66: 106-112
20. Larhammar D, Ericsson A, Persson H (1987) Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci USA 84: 2068-2072
21. Lane JD, Nadi NS, McBride WJ, Aprison MH, Kusano K (1977) Contents of serotonin, norepinephrine and dopamine in the cerebrum of "staggerer", "weaver" and "nervous" neurologically mutant mice. J Neurochem 29: 349-350
22. Lindefors N (1993) Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog Neuropsychopharmacol Biol Psychiatry 17: 887-903
23. Lindefors N, Brene S, Herrera-Marschitz M, Persson H (1989) Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Exp Brain Res 77: 611-620
24. Marley PD, Emson PC, Rehfeld JF (1982) Effect of 6-hydroxydopamine lesions of the medial forebrain bundle on the distribution of cholecystokinin in rat forebrain. Brain Res 252: 382-385
25. Matsui K, Masui A, Kato N, Adachi K (1993) Levels of somatostatin and cholecystokinin in the brain of ataxic mutant mice. Life Sci 53: 333-340
26. McMahon CD, Chapin LT, Lookingland KJ, Tucker HA (1998) Stimulation of dopamine D1 receptors increases activity of periventricular somatostatin neurons and suppress concentrations of growth hormone. Domest Anim Endocrinol 15(4): 257-265
27. Mengod G, Goudsmit E, Probst A, Palacios JM (1992a) In situ hybridization histochemistry in the human hypohalamus. Prog Brain Res 93: 45-55
28. Mengod G, Rigo M, Savasta M, Probst A, Palacios JM (1992b) Regional distribution of neuropeptide somatostatin gene expression in the human brain. Synapse 12: 62-74
29. Meziane H, Devigne C, Tramu G, Soumireu-Mourat B (1997) Distribution of cholecystokinin immunoreactivity in the BALB/c mouse forebrain: an immunocytochemical study. J Chem Neuroanat 12: 191-209
30. 3H]glutamate binding sites and AMPA receptor subunit RNA transcripts in the striatum of normal and weaver mutant mice and effects of ventral mesencephalic grafts. Cell Transpl 8: 11-23
31. Montminy MR, Low MJ, Tapia Arancibia L, Reichlin S, Mandel G, Goodman RH (1986) Cyclic AMP regulates somatostatin mRNA accumulation in primary diencephalic cultures and in transferred fibroblast cells. J Neurosci 6: 1171-1176
32. Moukhles H, Nieoullon A, Daszuta A (1992) Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalic cells. Neuroscience 47: 781-792
33. Nitsch C, Wolfrum G, Schaefer F, Scotti AL, Unger J (1993) Opposite effects of intranigral ibotenic acid and 6-hydroxydopamine lesions on motor behaviour and on striatal neuropeptide Y neurons. Brain Res Bull 30: 21-32
34. Normand ET, Popovici B, Onteniente D, Fellman D, Piatier-Tonneau C, Auffray C, Bloch B (1988) Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Brain Res 439: 39-46
35. Parent A, Sato F, Wu Y, Gauthier J, Levesque M, Parent M (2000) Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci 23(10): S20-S27
36. Pirot S, Godbout R, Mantz J, Tassin J-P, Glowinski J, Thierry AM (1992) Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience 49: 857-865
37. Roffler-Tarlov S, Graybiel AM (1986) Expression of the weaver gene in dopamine-containing neural systems is dose-dependent and affects both striatal and non-striatal regions. J Neurosci 6: 3319-3330
38. Salin P, Kerkerian L, Nieoullon A (1990a) Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway. Exp Brain Res 81: 363-371
39. Salin P, Kerkerian-Le Goff L, Heidet V, Epelbaum J, Nieoullon A (1990b) Somatostatin immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions. Brain Res 521: 23-32
40. Savasta M, Palacios JM, Mengod G (1988) Regional localization of the mRNA coding for the neuropeptide cholecystokinin in the rat brain studied by in situ hybridization. Neurosci Lett 93: 132-138
41. Savasta M, Ruberte E, Palacios JM, Mengod G (1989) The colocalization of cholecystokinin and tyrosine hydroxylase mRNA in mesencephalic dopaminergic neurons in the rat brain examined by in situ hybridization. Neuroscience 29: 363-369
42. Savasta M, Palacios JM, Mengod G (1990) Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization. Mol Brain Res 7: 91-104
43. Schiffmann SN, Vanderhaeghen JJ (1992) Lesion of the nigrostriatal pathway induces cholecystokinin messenger RNA expression in the rat striatum. An in situ hybridization histochemistry study. Neuroscience 50: 551-557
44. Schmidt MJ, Sawyer BD, Perry KW, Fuller RW, Foreman MM, Ghetti B (1982) Dopamine deficiency in the weaver mutant mouse. J Neurosci 2: 376-380
45. Sesack SR, Bunney BS (1989) Pharmacological characterization of the receptor mediated electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microintophoretic study. J Pharmacol Exp Ther 248: 1323-1333
46. Soghomonian JJ, Chesselet MF (1991) Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus. Neuroscience 42: 49-59
47. Solà C, Mengod G, Ghetti B, Palacios JM, Triarhou LC (1993) Regional distribution of the alternatively spliced isoforms of βAPP RNA transcript in the brain of normal, heterozygous and homozygous weaver mutant mice as revealed by in situ hybridization histochemistry. Mol Brain Res 17: 340-346
48. A receptor balance by functional mesencephalic dopaminergic grafts in mice with hereditary Parkinsonism. Exp Neurol 157: 259-267
49. Stoof JC, Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35: 2281-2296
50. Tavianini MA, Hayes TE, Magazin MD, Minth CD, Dixon JE (1984) Isolation, characterization, and DNA sequence of the rat somatostatin gene. J Biol Chem 259: 11798-11803
51. Thermos K, Radke J, Kastellakis A, Anagnostakis Y, Spyraki C (1996) Dopamine-serotonin interactions in the rat striatum: an in vivo microdialysis study. Synapse 22: 209-216
52. Triarhou LC (1992) Weaver gene expression in central nervous system. Meth Neurosci 9: 209-227
53. 2 receptors in rat medial prefrontal cortex. J Neurosci 13: 2551-2564
54. Voigt MM, Uhl GR (1988) Preprocholecystokinin mRNA in rat brain: regional expression includes thalamus. Mol Brain Res 4: 247-253
55. Voorn P, Roest G, Groenewegen HJ (1987) Increase of enkephalin and decrease of substantia P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions. Brain Res 412: 391-396